For example, in prostate cancer, SOX5 has been shown to be significantly upregulated in prostate cancer tissue, and overexpression of SOX5 is associated with larger tumor size, later clinical stage, and poorer prognosis (58). The gene discussed is SOX5; the disease is prostate carcinoma.